Health Care Price Transparency and Economic Theory

JAMA ◽  
2014 ◽  
Vol 312 (16) ◽  
pp. 1642 ◽  
Author(s):  
Uwe E. Reinhardt
Author(s):  
Ateev Mehrotra ◽  
Tyler Brannen ◽  
Anna D. Sinaiko

Author(s):  
Olga Vasylyeva

Economic theory must be tested by reality to prove that the goal is achievable and reproducible. However, health care economics do not always theorize based on modern-day medical practice, which results in detachment of some economic recommendations from real-life medicine. The theory of “moral hazard” assumes that patients will utilize more medical services if they transfer the risk of cost to insurances. In this article, we will revisit the understanding of appropriate avoidance of medical services and incorporate no-show rate, avoidance of care, and nonadherence into the concept of health services utilization. The primary goal of this interdisciplinary commentary is to bridge economic theory with clinical practice. It is written from the perspective of a clinical practitioner, who applies realities of everyday medicine to economic reasoning. The author hopes that this abstract will extend the field of vision of health care economics.   


2013 ◽  
Vol 4 ◽  
Author(s):  
S. Walzer ◽  
M. Nuijten ◽  
C. Wiesner ◽  
K. Kaier ◽  
P-O. Johansson ◽  
...  

JAMA Surgery ◽  
2020 ◽  
Vol 155 (7) ◽  
pp. 544
Author(s):  
Hillary E. Jenny ◽  
Brenna E. Jenny

Author(s):  
Rebecca A. Gourevitch ◽  
Sunita Desai ◽  
Andrew L. Hicks ◽  
Laura A. Hatfield ◽  
Michael E. Chernew ◽  
...  

Despite the recent proliferation of price transparency tools, consumer use and awareness of these tools is low. Better strategies to increase the use of price transparency tools are needed. To inform such efforts, we studied who is most likely to use a price transparency tool. We conducted a cross-sectional study of use of the Truven Treatment Cost Calculator among employees at 2 large companies for the 12 months following the introduction of the tool in 2011-2012. We examined frequency of sign-ons and used multivariate logistic regression to identify which demographic and health care factors were associated with greater use of the tool. Among the 70 408 families offered the tool, 7885 (11%) used it at least once and 854 (1%) used it at least 3 times in the study period. Greater use of the tool was associated with younger age, living in a higher income community, and having a higher deductible. Families with moderate annual out-of-pocket medical spending ($1000-$2779) were also more likely to use the tool. Consistent with prior work, we find use of this price transparency tool is low and not sustained over time. Employers and payers need to pursue strategies to increase interest in and engagement with health care price information, particularly among consumers with higher medical spending.


2011 ◽  
Vol 364 (10) ◽  
pp. 891-894 ◽  
Author(s):  
Anna D. Sinaiko ◽  
Meredith B. Rosenthal

2016 ◽  
Vol 35 (4) ◽  
pp. 662-670 ◽  
Author(s):  
Anna D. Sinaiko ◽  
Meredith B. Rosenthal

Sign in / Sign up

Export Citation Format

Share Document